Skip to content
Screener

Book value per share at other companies

MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX
$9.40+33.4%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$4.34-42.5%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$12.30-8.7%
VAN
Vivani MedicalVANI
$0.23+19.7%
uniQure logo
uniQureQURE
$4.89+6,801%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$0.72-271%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$45.7M-6.6%
Net income-$43.4M-4.8%
EPS (diluted)-$0.39+15.2%

Balance sheet

See full
Cash & equivalents$49.3M-15.1%
Total debt$5.3M-11.9%
Total equity$239.2M+42.5%
Total assets$264.6M+36.0%

Cash flow

See full
Operating cash flow-$31.4M-24.5%
CapEx$86.0K+330%
Free cash flow-$28.0M+52.6%

Valuation

See full
Market cap$2.7B+269%
Enterprise value$2.65B+291%

Profitability

See full
Gross margin100%+6.9pp
Operating margin-47,349.8%-47,409pp
Net margin-45,096.2%-45,152pp
FCF margin-39,826.7%-39,847pp

Returns & leverage

See full
Return on equity-74.7%-9.5pp
Debt / equity0.0×
Current ratio12.1×+3.4×

Where this comes from

Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:04 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336682

FAQ

What is Amylyx Pharmaceuticals, Inc.'s book value per share?
Amylyx Pharmaceuticals, Inc. (AMLX) reported book value per share of $2.15 in Q2 2026.
How has Amylyx Pharmaceuticals, Inc.'s book value per share changed year-over-year?
Amylyx Pharmaceuticals, Inc.'s book value per share increased by 14.2% year-over-year, from $1.88 to $2.15.
What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s book value per share?
Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s book value per share has grown at a -38.8% compound annual growth rate (CAGR), from -$22.95 to $3.23.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Amylyx Pharmaceuticals, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude